Yuki Sakamoto/LinkedIn
Sep 30, 2025, 15:34
Yuki Sakamoto and Colleagues Share Insights on Infarct Growth After Successful Mechanical Thrombectomy
International Journal of Stroke (IJS) shared on X:
”In patients who underwent successful mechanical thrombectomy, infarct growth was associated with:
- Extremely low systolic BP recanalization
- Systolic BP variation after recanalization.
Read more here.”
Read the full article in IJS/Sage Journals.
Article: Associations between systolic blood pressure and infarct growth after thrombectomy for acute stroke: A retrospective observational study
Authors: Yuki Sakamoto, Junya Aoki, Yuji Nishi, Sotaro Shoda, Michika Sakamoto, Kentaro Suzuki, Takehiro Katano, Akihito Kutsuna, Ryutaro Kimura, Kaito Watanabe, Chinatsu Sakuragi, Takashi Shimoyama, Kazumi Kimura

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
Akihito Kutsuna
Chinatsu Sakuragi
Health
Hematology
Hemostasis
Hemostasis Today
Infarct Growth
Junya Aoki
Kaito Watanabe
Kazumi Kimura
Kentaro Suzuki
Mechanical thrombectomy
Medicine
Michika Sakamoto
Recanalization
Ryutaro Kimura
Sotaro Shoda
Takashi Shimoyama
Takehiro Katano
thrombosis
Yuji Nishi
Yuki Sakamoto
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
